 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/03/2017 |
$1.50 |
$1.54 |
$1.49 |
$1.54 |
260.10K | | 01/04/2017 |
$1.55 |
$1.68 |
$1.54 |
$1.59 |
1.44M | | 01/05/2017 |
$1.60 |
$1.62 |
$1.48 |
$1.55 |
447.40K | | 01/06/2017 |
$1.56 |
$1.66 |
$1.56 |
$1.63 |
1.29M | | 01/09/2017 |
$1.63 |
$1.65 |
$1.53 |
$1.56 |
427.80K |
|
|
| ProNAi Therapeutics is a clinical-stage oncology company. Co.'s key product candidate, PNT2258, is based on its DNA interference (DNAi) technology platform. PNT2258 is designed to target BCL2, an oncogene that is a gatekeeper of the programmed cell death process known as apoptosis and has been linked to several forms of cancer. PNT2258 is a formulation of Co.'s single-stranded 24-base DNAi oligonucleotide (PNT100), encapsulated in the SMARTICLES Lipid Nanoparticle. Co. has conducted two clinical trials with single-agent PNT2258: a Phase 1 safety trial in patients with relapsed or refractory solid tumors and a Phase 2 trial in patients with relapsed or refractory non-Hodgkin's lymphoma. | |
|
DNAI (DNAI) has the following price history information. Looking back at DNAI historical stock prices for the last five trading days, on January 03, 2017, DNAI opened at $1.50, traded as high as $1.54 and as low as $1.49, and closed at $1.54. Trading volume was a total of 260.10K shares. On January 04, 2017, DNAI opened at $1.55, traded as high as $1.68 and as low as $1.54, and closed at $1.59. Trading volume was a total of 1.44M shares. On January 05, 2017, DNAI opened at $1.60, traded as high as $1.62 and as low as $1.48, and closed at $1.55. Trading volume was a total of 447.40K shares. On January 06, 2017, DNAI opened at $1.56, traded as high as $1.66 and as low as $1.56, and closed at $1.63. Trading volume was a total of 1.29M shares. On January 09, 2017, DNAI opened at $1.63, traded as high as $1.65 and as low as $1.53, and closed at $1.56. Trading volume was a total of 427.80K shares.
DNAI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into DNAI shares, starting with a $10,000 purchase of DNAI, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/09/2016 |
|
| End date: |
01/09/2017 |
|
| Start price/share: |
$6.75 |
|
| End price/share: |
$1.56 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-76.89% |
|
| Annualized Gain: |
-83.77% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2,311.00 |
|
| Years: |
0.92 |
|
|
|
| Date |
Close |
| 01/03/2017 | $1.54 | | 01/04/2017 | $1.59 | | 01/05/2017 | $1.55 | | 01/06/2017 | $1.63 | | 01/09/2017 | $1.56 |
|
|
Free DNAI Email Alerts:
